How male hormones affect the immune system in glioblastoma
Treatments studied
Part of Cancer clinical trials.
This study looks at how hormones called androgens (like testosterone) might change the immune cells in glioblastoma tumors. It could help doctors understand why some treatments work better for certain patients.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 55 years old.
- You have been newly diagnosed with glioblastoma (GBM).
- You had surgery to remove part or all of the tumor.
- You are eligible for chemotherapy and radiation therapy.
- You do not have an active autoimmune disorder or active infection.
- You have a tumor sample available that was taken during your surgery.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at mental health and suicidal thoughts in people with glioblastoma after they finish radiotherapy. Understanding these factors can help improve support and care for patients.
This trial is testing whether a drug called G-CSF (which helps boost white blood cells) can help people with glioblastoma who are already receiving standard treatment with radiation and chemotherapy (temozolomide). It aims to see if G-CSF can reduce side effects and improve outcomes.
This study looks at whether exposure to pesticides affects survival and tumor growth in people with glioblastoma, a type of brain cancer. It may help researchers understand if environmental factors influence the disease, which could lead to better treatments or prevention.
This trial studies a new approach that aims to help your immune system recognize glioblastoma, a type of brain tumor. If you’re eligible, you may be asked to receive treatments designed to target specific tumor “antigens” (markers).
This trial tests a new approach using immune cells called cytokine-induced killer cells to treat glioblastoma. It aims to find the best way to prepare these cells to fight the tumor.
This study follows people newly diagnosed with glioblastoma to see how certain lab signals (MMP2 and MMP9) match up with MRI scan features. It may help doctors better understand the disease and how it appears on imaging, but it’s mainly observational.
Hear when a new Glioblastoma (GBM) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.